United Therapeutics announced today that it will report its third quarter 2017 financial results before the market opens on Wednesday, October 25, 2017.
|
|
| [19-October-2017] |
|
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 19, 2017 /PRNewswire/ -- United Therapeutics Corporation announced today that it will report its third quarter 2017 financial results before the market opens on Wednesday, October 25, 2017. United Therapeutics will host a teleconference on Wednesday, October 25, 2017, at 9:00 a.m. Eastern Time. The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533. A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 1-855-859-2056, with international callers dialing 1-404-537-3406, and using access code: 97086326. This teleconference is also being webcast and can be accessed via United Therapeutics' website at http://ir.unither.com/events.cfm. [uthr-g] About United Therapeutics United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. View original content:http://www.prnewswire.com/news-releases/united-therapeutics-corporation-to-report-third-quarter-2017-financial-results-before-the-market-opens-on-wednesday-october-25-2017-300539302.html SOURCE United Therapeutics Corporation |
||
Company Codes: NASDAQ-NMS:UTHR |
